The results showed a clear pattern: People who had taken epilepsy drugs were more likely to have Parkinson’s disease. The ...
Sanofi has joined a growing list of drugmakers going after alpha-synuclein targeting drugs for Parkinson's disease, licensing a bispecific antibody from South Korea's ABL Bio in a deal that could ...
Getting a headache and feeling sick are common side-effects for many medicines. Indulging in risky sexual behaviour or pathological gambling – not so common. But a BBC investigation has highlighted ...
The drug is intended for patients experiencing ... The approval adds Onapgo to a growing list of infusion-based Parkinson’s treatments. AbbVie’s Vyalev (foscarbidopa and foslevodopa ...
Jan. 3, 2025 — Researchers uncovered new findings about involuntary muscle movements that come with long-term administration of Parkinson's drug ... 'Dancing the Blues Away' Seen in Brain ...
Researchers have discovered more about PINK1, a protein that’s directly tied to Parkinson’s disease. A team from Walter and Eliza Hall Institute in Australia has shown how the protein attaches to cell ...
A large case-control study suggests that calcium channel blockers are the only antihypertensives that reduce the risk for Parkinson disease ... of antihypertensive drugs: angiotensin-converting ...